Gianluca Miglio
Gianluca Miglio is a pharmacology professor at the University of Turin, known for his research on cancer therapies and the disparities in drug approval between the European Medicines Agency (Ema) and the U.S. Food and Drug Administration (Fda). His recent study highlights how over half of cancer drugs are approved for slightly different patient populations on either side of the Atlantic, raising concerns about access to treatment based on geography.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 7.00 | 0.05% | +0% | 60,461,826 | 30,081 | $2,000,000 | 995$ |
| Totals | 1 | 60,461,826 | 30,081 | $2,000,000 | 995$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Gianluca Miglio is a pharmacology professor at the University of Turin who discusses the differences in drug approval between the Ema and Fda.
7